Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

Fluke Biomedical Launches Mobile app

By BiotechDaily International staff writers
Posted on 18 Sep 2013
Image: The Fluke Biomedical Mobile app (Photo courtesy of Fluke Biomedical)
Image: The Fluke Biomedical Mobile app (Photo courtesy of Fluke Biomedical)
A new app helps Fluke Biomedical users’ access product material any time, by downloading device resources directly to their smartphone or tablet.

The Fluke Biomedical Information Center app is intended to improve customer service in the mobile realm and was designed with field service professionals in mind. Detailed product information is available for all biomedical, diagnostic imaging, radiation, and nuclear power products. Product updates and industry news are accessible any time, with or without a Wi-Fi connection.

The app provides multimedia material, including videos that demonstrate product functions and operation; push notifications of current product updates; and a download function that offers biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals access to product information, anytime and anywhere. The app covers all of Fluke Biomedical test and measurement equipment and services to the healthcare industry. The free app is compatible with iPad and requires iOS 6.0 software or later.

“We are tremendously excited to offer the new mobile app to medical device quality and safety professionals,” said Mandy Allen, field-marketing manager for Fluke Biomedical. “The app provides our customers with fast access to product information that will help them make informed decisions and obtain expert support when needed.”

Related Links:
Fluke Biomedical


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel

Precise Ion Irradiation Dosing Method Developed for Cancer Therapy

Scientists are employing nuclear physics principles to provide more effective approaches to radiotherapy treatment for cancer patients. Radiation therapy using heavy ions is best suitable for cancer patients with tumors that are difficult to access, such as in the brain. These particles scarcely damage the penetrated... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.